COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,785 Articles (22,523 medRxiv, 8,262 bioRxiv)

Most recent first Previous |  Page 2006: Articles 20051-20060  | Next

The impact of early public health interventions on SARS-CoV-2 transmission and evolution
Duchene, S., Featherstone, L., Freiesleben de Blasio, B., Holmes, E. C., Bohlin, J., Pettersson, J. H.- O.
10.1101/2020.11.18.20233767 — Posted: 2020-11-18
Assessing the impact of non-pharmaceutical interventions on the dynamics of COVID-19: A mathematical modelling study in the case of Ethiopia
Ejigu, B. A., Asfaw, M. D., Cavaleri, L., Abebaw, T., Nanyingi, M., Baylis, M.
10.1101/2020.11.16.20231746 — Posted: 2020-11-18
On short-term trends and predictions for COVID-19 in France and the USA: comparison with Australia
Tuckwell, H. C., Dorraki, M., Salamon, S. J., Allison, A., Abbott, D.
10.1101/2020.11.17.20233718 — Posted: 2020-11-18
Estimating COVID-19 Virus Prevalence from Records of Testing Rate and Test Positivity
Everts, A. J.
10.1101/2020.11.17.20233643 — Posted: 2020-11-18
COVID-19 critical care simulations: An international cross-sectional survey
Temsah, M. H., Alrabiaah, A., Al-Eyadhy, A., Al-Sohime, F., Al Huzaimi, A., Alamro, N., Alhasan, K., Upadhye, V., Jamal, A., Aljamaan, F., Arabi, Y. M., Lazarovici, M., Boker, A. M.
10.1101/2020.11.17.20233262 — Posted: 2020-11-18
Sustained expression of inflammatory monocytes and activated T cells in COVID-19 patients and recovered convalescent plasma donors
Trehanpati, N., Singh, R., Bajpai, M., Yadav, P., Maheshwari, A., Kumar, S., Agrawal, S., Kumar, J., Islam, M., Maras, J. S., Ramakrishna, G., Sarin, S. K.
10.1101/2020.11.17.20233668 — Posted: 2020-11-18
The decrease in hospitalizations for transient ischemic attack and ischemic stroke, especially in mild cases, during the COVID-19 epidemic in Japan.
Nagano, H., Takada, D., Shin, J.-h., Morishita, T., Kunisawa, S., Imanaka, Y.
10.1101/2020.11.17.20233692 — Posted: 2020-11-18
COVID-19: more than a little flu? Insights from the Swiss hospital-based surveillance of Influenza and COVID-19
Froehlich, G., De Kraker, M., Abbas, M., Keiser, O., Thiabaud, A., Roulens, M., Cusini, A., Flury, D., Schreiber, P., Buettcher, M., Corti, N., Vuichard-Gysin, D., Troillet, N., Sauser, J., Gaudenz, R., Damonti, L., Balmelli, C., Iten, A., Widmer, A., Harbarth, S., Sommerstein, R.
10.1101/2020.11.17.20233080 — Posted: 2020-11-18 Discussion: Onsite
Comparative Efficacy and Safety of Current Drugs against COVID-19: a Systematic Review and Net-work Meta Analysis
Li, Y., He, W.
10.1101/2020.11.16.20232884 — Posted: 2020-11-18
Detection of transmission change points during unlock-3 and unlock-4 measures controlling COVID-19 in India
Mandal, M., Mandal, S.
10.1101/2020.11.17.20233221 — Posted: 2020-11-18

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).